Pharma & Healthcare / Attention Deficit Hyperactivity Disorder (ADHD) Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Market Takeda, Johnson & Johnson, Novartis
Attention Deficit Hyperactivity Disorder (ADHD) Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key market Takeda, Johnson & Johnson, Novartis
Registering a CAGR of 6.8% over the forecast period of 2022-2027, the global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach the market value of US$ 24.8 billion in the year 2027 from US$ 22.6 billion in the year 2021.
Attention-deficit hyperactivity disorder is known as a brain disorder in which the patient is hyperactive, impulsive and has absenteeism of attention. The reason for this disorder is not yet identified but it is anticipated that a several factors such as genes, pre-natal brain injuries, exposure of toxins so forth are responsible for ADHD. Features such as the upsurge on emphasis and advancements in medical field to advance advanced products for ADHD and the growth in responsiveness about mental illness amongst people are the factors expected to boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the forecast period.
The report aspects discussed the profile of the top manufacturers of the global Attention Deficit Hyperactivity Disorder (ADHD) market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Attention Deficit Hyperactivity Disorder (ADHD) Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
What are the major Applications, Types and Regions for Attention Deficit Hyperactivity Disorder (ADHD) Market?
The stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs.
Retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies
North America dominates the attention-deficit hyperactivity disorder (ADHD) market since of the large volume of drug prescriptions every year and the growing of the product launches. Furthermore, the growth in the collaboration amongst the companies to improve the market penetration and for the product expansion which in turn will further boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the region during the forecast period. The European ADHD market is second only to developing technology and digital medications. The industry's expansion is due to an affluent medical device market and rising healthcare expenditure. The ADHD treatments market in Asia Pacific is also growing. The unmet demands and large patient population, as well as the availability of lower-cost ADHD medications, have all contributed to the market's rise.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Attention Deficit Hyperactivity Disorder (ADHD) Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Attention Deficit Hyperactivity Disorder (ADHD) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Attention Deficit Hyperactivity Disorder (ADHD) Market report scope?
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR
CAGR of 6.8% over the forecast period (2022-2027)
By Type
Stimulant
Non-stimulant
By Application
Hospital Pharmacy
Retail Pharmacy
By Companies
Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Number of Pages
131
Customization Available
Yes, the report can be customized as per your needs
Key Takeaways from this Attention Deficit Hyperactivity Disorder (ADHD) Report
Evaluate Attention Deficit Hyperactivity Disorder (ADHD) market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
Analyze the sales and distribution channels across geographies to enhance top-line revenues.
Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the Attention Deficit Hyperactivity Disorder (ADHD) market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
Frequently Asked Questions
What is the growth rate of Attention Deficit Hyperactivity Disorder (ADHD)Market?
The Attention Deficit Hyperactivity Disorder (ADHD)Market is growing at a CAGR of 6.8% over the next 5 years.
Who are the key players in Attention Deficit Hyperactivity Disorder (ADHD)Market?
Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH
What are the significant types of Attention Deficit Hyperactivity Disorder (ADHD)Market?
Stimulant, Non-stimulant
What are the major end-use applications of Attention Deficit Hyperactivity Disorder (ADHD)Market?
Hospital Pharmacy, Retail Pharmacy
On the basis of application, Which segment is likely to hold the major share in the Attention Deficit Hyperactivity Disorder (ADHD)Market?
Retail Pharmacy segment to hold the largest share in Attention Deficit Hyperactivity Disorder (ADHD)market
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
INTRODUCTION
MARKET DEFINITION
MARKET DYNAMICS
MARKET SEGMENTATION
REPORT TIMELINES
KEY STAKEHOLDERS
RESEARCH METHODOLOGY
DATA MINING
SECONDARY RESEARCH
PRIMARY RESEARCH
SUBJECT MATTER EXPERT ADVICE
QUALITY CHECK
FINAL REVIEW
DATA TRIANGULATION
BOTTOM-UP APPROACH
TOP-DOWN APPROACH
RESEARCH FLOW
EXECUTIVE SUMMARY
INTRODUCTION
GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) BY TYPES
GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) BY APPLICATION
MARKET DYNAMICS
DRIVERS
INCREASING DEMAND FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) RESTRAINTS
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.